Approval

Bahrain approves Gan & Lee's insulin glargine prefilled pen

Bahrain's health regulator registered Gan & Lee Pharmaceuticals' insulin glargine in a prefilled pen. Bahrain follows the UAE and Oman as the third Gulf Cooperation Council market to clear the product. Roughly 197,600 adults there were living with diabetes in 2024, a prevalence of 17.8%.

Written by Gosset from public sources. Source types: News article. Sources are available to Gosset users. Log in to see them.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call